Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Author:
Global | Publication | May 2018
Pursuant to a new regulation made under the Cannabis Act, 2017, S.O. 2017, (the Ontario Cannabis Act), activities respecting industrial hemp will not be regulated pursuant to the Ontario Cannabis Act.
The regulation specifically carves out from the jurisdiction of the Ontario Cannabis Act “a cannabis plant or any part of a cannabis plant whose leaves and flowering heads do not contain more than 0.3% THC w/w.” This low-THC cannabis plant is better known as industrial hemp in the cannabis industry.
As discussed in our previous update, the Ontario Cannabis Act will regulate the sale, distribution, purchase, possession, cultivation, and propagation and harvesting of adult-use cannabis in Ontario and aims to align Ontario with the federal legalization of cannabis anticipated to happen later this year.
While alternative regulations for activities respecting industrial hemp have not yet been provided, according to at least some sources, this new regulation may be “welcome news for many Canadian hemp entrepreneurs” as some may see this as “an opportunity to move forward with CBD.” Perhaps most exciting for industry is the possibility of increased market access (in Ontario at least) for hemp-derived CBD, one of the most highly sought-after cannabinoids, which happens to be plentiful in the industrial hemp plant.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023